FDA Approved: FELBAMATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Felbamate submitted by Mylan Pharmaceuticals Inc., updating the approved use of Felbamate under NDA020189.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome
• Partial Seizures

Drugs mentioned

• FELBAMATE (felbamate)

Snippet

SUPPL AP for FELBAMATE (FELBAMATE)